Scotiabank Reiterates Buy Rating on American Healthcare REIT

Scotiabank maintains its buy rating on American Healthcare REIT with a $51 price target.

Written by EarningsIQ · Published Jun 18, 2026, 10:01 AM EDT · Updated Jun 18, 2026, 12:01 PM EDT

Key Points

Scotiabank reiterated its buy rating on American Healthcare REIT, Inc. (NYSE:AHR) with a price target of $51 as of June 18, 2026.
Shares of AHR are trading around $46.47, with a market cap of approximately $9.62 billion and a P/E ratio of 78.8.
BlackRock, Inc. increased its holdings in AHR by 8.6 million shares, now holding about 28.7 million shares worth $1.36 billion.

Scotiabank analyst Nicholas Yulico has reiterated a buy rating on American Healthcare REIT, Inc. (NYSE:AHR), maintaining a price target of $51. This update, released on June 18, 2026, suggests continued confidence in the company's potential.

Other Institutional Activity in American Healthcare REIT

Several institutional investors have adjusted their holdings in American Healthcare REIT. BlackRock, Inc. increased its position by 8.6 million shares, now holding approximately 28.7 million shares valued at $1.36 billion. Vanguard Portfolio Management LLC established a new position with about 16.1 million shares worth $760.4 million. State Street Corp added 2.5 million shares, bringing its total to 9.5 million shares valued at $452.5 million. Wellington Management Group LLP slightly increased its stake by 361,000 shares, holding a total of 8.3 million shares valued at $390.7 million.

American Healthcare REIT Stock Snapshot

Shares of American Healthcare REIT are trading near $46.47. The company has a market cap of about $9.62 billion and a P/E ratio of 78.8. It has a forward P/E of 54.1 and a beta of 0.805. The stock's 52-week range spans from $35.46 to $54.67, with a 50-day moving average of $49.15 and a 200-day moving average of $47.65. The current ratio stands at 1.005, the quick ratio at 0.792, and the debt-to-equity ratio at 47.614.

Recent Earnings

American Healthcare REIT reported revenue of approximately $2.37 billion, with a revenue growth rate of 20.9%. The company achieved a net margin of 4.2% and a return on equity of 3.49%. Earnings per share came in at $0.59. The next earnings report is expected on August 6, 2026.

Dividend

The company offers an annual dividend rate of $1.00, yielding 2.13%. The dividend payout ratio is relatively high at 169.49%.

Insider Buying and Selling at American Healthcare REIT, Inc.

Recent insider activity includes Mark Foster, EVP, GC & Secretary, selling 2,000 shares on June 1, 2026, at an average price of $48.32 under a pre-planned trading plan. Earlier, on April 6, 2026, Danny Prosky bought 15,924 shares, while also selling 8,596 shares on the same day.

Analysts Set New Price Targets

On June 18, 2026, Scotiabank maintained its buy rating with a $51 price target. Keybanc also maintained a buy rating on May 28, 2026, with a target of $58. RBC Capital kept its buy rating on May 26, 2026, with a target of $56. The consensus among analysts is a buy recommendation, with a mean target price of $58.85 based on 13 analyst opinions.

About American Healthcare REIT

American Healthcare REIT, Inc., headquartered in Irvine, California, is a self-managed real estate investment trust (REIT) specializing in healthcare facilities. It owns a diverse portfolio of healthcare properties across the U.S., U.K., and Isle of Man, focusing on senior housing, skilled nursing facilities, and outpatient medical buildings. Led by CEO Jeffrey T. Hanson, the company employs 121 people and operates under the RIDEA structure, aiming to acquire and develop income-generating healthcare assets.

Bottom Line

Scotiabank's reiteration of a buy rating for American Healthcare REIT reflects ongoing confidence in its market performance. Investors keep a close eye on such ratings, as they provide insights into the stock's potential. However, it's important to remember that these are backward-looking assessments and may not indicate future performance.